Clinical Trial

Non Dilation on the Central Venous Catheterization(NDCVC-01)

Study acronym: NDCVC-01
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated October 22, 2024 (before its estimated May 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The central venous catheter is widely used and used in high dosage, and various complications such as hematoma, hemopneumothorax and arterial puncture may occur during puncture and use. In addition to conventional techniques, studies have been done to improve the success rate of puncture and reduce the incidence of complications by modifying different procedures. However, among the complications caused by the procedure of percutaneous catheter placement, the fatal bleeding caused by skin dilation may threaten the patient' s life. There are few studies on dilators and skin dilation steps at home and abroad. In this study, the conventional puncture technique was improved and the skin dilation step was omitted, hoping to reduce complications, reduce puncture time, improve efficiency and improve patient comfort on the premise of ensuring the success rate of catheterization.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06652191
Lead Sponsor Sixth Affiliated Hospital, Sun Yat-sen University
Conditions the Success Rate of Non Dilation on the Central Venous Catheterization
Enrollment 336 participants
Start Date 2024-10-28
Primary Completion 2025-05-31 (estimated)
Study Completion 2025-05-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-22